-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BpYAydAiLrAn94qNe0BbfCoekFTPcaFfXopuAJz3OftMGBaZlqoxbcf7Buk046V1 92gEBsfPzs8vQ12SMxRWNQ== /in/edgar/work/20000908/0000950109-00-003865/0000950109-00-003865.txt : 20000922 0000950109-00-003865.hdr.sgml : 20000922 ACCESSION NUMBER: 0000950109-00-003865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20000801 FILED AS OF DATE: 20000908 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MOORE MEDICAL CORP CENTRAL INDEX KEY: 0000074691 STANDARD INDUSTRIAL CLASSIFICATION: [5047 ] IRS NUMBER: 221897821 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: 4 SEC ACT: SEC FILE NUMBER: 001-08903 FILM NUMBER: 719511 BUSINESS ADDRESS: STREET 1: PO BOX 1500 STREET 2: 389 JOHN DOWNEY DR CITY: NEW BRITAIN STATE: CT ZIP: 06050 BUSINESS PHONE: 2038263600 MAIL ADDRESS: STREET 1: 389 JOHN DOWNEY DRIVE STREET 2: 389 JOHN DOWNEY DRIVE CITY: NEW BRITAIN STATE: CT ZIP: 06050 FORMER COMPANY: FORMER CONFORMED NAME: OPTEL CORP DATE OF NAME CHANGE: 19850611 COMPANY DATA: COMPANY CONFORMED NAME: MOORE MEDICAL CORP CENTRAL INDEX KEY: 0000074691 STANDARD INDUSTRIAL CLASSIFICATION: [5047 ]DIRECTOR IRS NUMBER: 221897821 STATE OF INCORPORATION: DE FISCAL YEAR END: 0102 FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: PO BOX 1500 STREET 2: 389 JOHN DOWNEY DR CITY: NEW BRITAIN STATE: CT ZIP: 06050 BUSINESS PHONE: 2038263600 MAIL ADDRESS: STREET 1: 389 JOHN DOWNEY DRIVE STREET 2: 389 JOHN DOWNEY DRIVE CITY: NEW BRITAIN STATE: CT ZIP: 06050 FORMER COMPANY: FORMER CONFORMED NAME: OPTEL CORP DATE OF NAME CHANGE: 19850611 4 1 0001.txt FORM 4 - ---------- | FORM 4 | U.S. SECURITIES AND EXCHANGE COMMISSION - ---------- Washington, D.C. 20549 [_] Check box if no STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP longer subject to Section 16. Filed pursuant to Section 16(a) of the Securities Form 4 or Form 5 Exchange Act of 1934, Section 17(a) of the obligations may Public Utility Holding Company Act of 1935 or continue. See Section 30(f) of the Investment Company Act of 1940 Instruction 1(b). - ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting 2. Issuer Name and Ticker or Trading 6. Relationship of Reporting Person* Symbol Persons to Issuer (Check all applicable) X Director __ 10% Owner --- ___ Officer (give __ Other (specify title below) below) Brody, Christopher W. Moore Medical Corp. - ------------------------------------------------------------------------------------------------------------------------------------ (Last) (First) (Middle) 3. IRS or Identification 4. Statement for 7. Individual or Joint/Group Filing c/o Vantage Partners, LLC Number of Reporting Month/Year (Check applicable line) 610 Fifth Ave., 7/th/ floor Person if an Entity (Voluntary) 8/00 - ----------------------------------- ----------------- X Form filed by one Reporting Person ----- (Street) 5. If Amendment, Date of _____ Form filed by more than one Reporting Original Person (Month/Year) New York, NY 10020 - ------------------------------------------------------------------------------------------------------------------------------------ (City) (State) (Zip) Table 1 - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of 2. Trans- 3. Trans- 4. Securities Acquired 5. Amount of 6. Owner- 7. Nature Security action action (A) or Disposed of Securities ship of In- (Instr. 3) Date Code (D) (Instr. 3, 4 Beneficially Form: direct (Month/ (Instr. 8) and 5) Owned at Direct Bene- Day/ ---------------------------------------- End of (D) or ficial Year) Month Indirect Owner- Code V Amount (A) Price (Instr. 3 and 4) (I) ship or (Instr. 4) (D) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 08/01/00 P 2,500 A $6.02 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 08/01/00 P 15,000 A $6.08 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 08/02/00 P 10,000 A $6.06 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 08/04/00 P 7,500 A $6.06 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 08/07/00 P 65,000 A $6.06 - ------------------------------------------------------------------------------------------------------------------------------------ Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned (Continued) - ------------------------------------------------------------------------------------------------------------------------------------ Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned - ------------------------------------------------------------------------------------------------------------------------------------ 1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature of action action or Disposed of (D) Securities ship of In- Security Date Code (Instr. 3, 4 and 5) Beneficially Form: direct (Instr. 3) (Month/ (Instr. 8) Owned at Direct Bene- Day/ ----------------------------------------------- End of (D) or ficial Year) Month Indirect Owner- Code V Amount (A) or Price (Instr. 3 and 4) (I) ship (D) (Instr. 4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 160,000(1) D - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock - - - - 50,000 I (2) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
*If the Form is filed by more than one reporting person, see Instruction 5(b)(v). Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls warrants options, convertible securities)
- ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of 2. Conversion 3. Trans- 4. Trans- 5. Number 6. Date Exercisable 7. Title and Amount 8. Price Derivative of Exercise action action of Derivative and Expiration of Underlying of Security Price of Date Code Securities Date (Month/ Securities Deriva- (Instruction Derivative (Month/ Instruc- Acquired (A) Day/year) (Instructions 3 tive 3) Security Day/ tion 8) or Disposed and 4) Security year) of (D) (Instr. 3, 4 Instruc- and 5) tion 5) ----------------------------------------------------------------------------- Code V A D Date Expira-tion Title Amount Exercis- Date or able Number of Shares - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - --------------------------------------------- 9. Number 10. Owner- 11. Nature of of ship Indirect Derivation Form of Beneficial Securities Derivative Ownership Benefici- Security: (Instruction ally Direct (D) 4) Owned at Indirect (I) End of (Instruction Month 4) (Instruc- tion 4) - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- - --------------------------------------------- ====================================================================================================================================
Explanation of Responses: (1) Includes 10,000 shares which are subject to a right of purchase held by a third party unaffiliated with the issuer. (2) The shares are held by Vantage Venture Partners, LP; Mr. Brody is Chairman of its general partner, Vantage Partners, LLC. Mr. Brody has a partial indirect interest in Vantage Venture Partners, LP. /s/ Christopher W. Brody 9/3/00 -------------------------------- -------------- **Signature of Reporting Person Date Christopher W. Brody ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78fb(a). Note: File three copies of this form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Page 2 -----END PRIVACY-ENHANCED MESSAGE-----